Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 81829 | (S)-1-Boc-2-Propylpiperazine | 888972-67-6 | 98% | -1-Boc-2-Propylpiperazine-cas-888972-67-6.png) |
| Coming soon! | ||||
| 81828 | (S)-1-Boc-(2-Hydroxymethyl)piperazine | 1030377-21-9 | 98% | -1-Boc-(2-Hydroxymethyl)piperazine-cas-1030377-21-9.png) |
| Coming soon! | ||||
| 81825 | (S)-1-Boc-3-(Hydroxymethyl)piperazine | 314741-40-7 | 98% | -1-Boc-3-(Hydroxymethyl)piperazine-cas-314741-40-7.png) |
| Coming soon! | ||||
| 81823 | (S)-Piperazin-2-ylmethanol dihydrochloride | 149629-73-2 | 98% | -Piperazin-2-ylmethanoldihydrochloride-cas-149629-73-2.png) |
| Coming soon! | ||||
| 81816 | (2S)-4-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid | 848482-93-9 | 98% | -4-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylicacid-cas-848482-93-9.png) |
| Coming soon! | ||||
| 81813 | (S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride | 1217720-49-4 | 98% | -Benzyl2-methylpiperazine-1-carboxylatehydrochloride-cas-1217720-49-4.png) |
| Coming soon! | ||||
| 81731 | (S)-4-N-Boc-2-methylpiperazine | 147081-29-6 | 98% | -4-N-Boc-2-methylpiperazine-cas-147081-29-6.png) |
| Coming soon! | ||||
| 81718 | (S)-Piperazine-2-carboxylic acid dihydrochloride | 158663-69-5 | 98% | -Piperazine-2-carboxylicaciddihydrochloride-cas-158663-69-5.png) |
| Coming soon! | ||||
| 81017 | (1S)-1-(4-chloro-3-methylphenyl)ethanamine | 943760-74-5 | 97% | -1-(4-chloro-3-methylphenyl)ethanamine-cas-943760-74-5.png) |
| Coming soon! | ||||
| 81015 | (1S)-1-(4-fluoro-3-methoxyphenyl)ethanamine | 870849-59-5 | 97% | -1-(4-fluoro-3-methoxyphenyl)ethanamine-cas-870849-59-5.png) |
| Coming soon! | ||||
| 80701 | SR9243 | 1613028-81-1 | 97% |  |
| SR9243 is a LXR inverse agonist that induces LXR-corepressor interaction, which shows | ||||
| 60301 | Sapitinib(AZD8931) | 848942-61-0 | ≧98.0% | -cas-848942-61-0.png) |
| AZD8931(Sapitinib)is a novel potent reversible small molecule epidermal growth factor | ||||
| 52754 | SU6656 | 330161-87-0 | 98% |  |
| SU 6656 is a selective inhibitor of Src kinases, Including Src, Yes, Lyn, and Fyn (IC | ||||
| 52751 | SBE13 Hydrochloride | 1052532-15-6 | 98% |  |
| SBE13 Hcl is a potent and selective PLK1 with IC50 of 0.2 nM; no inhibition om Aurora | ||||
| 52737 | SGI-1027 | 1020149-73-8 | 98% |  |
| SGI-1027 is a potent and selective inhibitor of DNA methyltransferase (DNMT) with IC5 | ||||
| 52714 | SB225002 | 182498-32-4 | 98% |  |
| SB225002 is a potent and selective non-peptide inhibitor of CXCR2 with IC50 of 22 nM; | ||||
| 52579 | SU9516 | 377090-84-1 | 98% |  |
| SU-9516 is a selective CDK2 inhibtor with IC50 of 22 nM; less potent for CDK1/CDK4(IC | ||||
| 52575 | SCH900776 | 891494-63-6 | 98% |  |
| SCH900776 is a potent, selective and orally bioavailable inhibitor of checkpoint kina | ||||
| 52571 | Selumetinib | 606143-52-6 | 98% |  |
| Selumetinib (AZD6244; ARRY-142886) is a potent, highly selective MEK1 inhibitor with | ||||
| 52549 | Siramesine hydrochloride | 224177-60-0 | 98% | |
| Siramesine(Lu 28-179) Hcl is a selective sigma-2 receptor agonist, which has been sho | ||||
| 52548 | Siramesine | 147817-50-3 | 98% |  |
| Siramesine(Lu 28-179) is a selective sigma-2 receptor agonist, which has been shown t | ||||
| 52546 | S1RA | 878141-96-9 | 98% |  |
| S1RA(E-52862) is a potent and selective sigma-1 receptor(1R, Ki=17 nM) antagonist, sh | ||||
| 52537 | SMI-4a | 438190-29-5 | 98% |  |
| SMI-4a is a selective ATP-competitive Pim-1 kinase inhibitor with an IC50 of 21 nM fo | ||||
| 52536 | SKLB610 | 1125780-41-7 | 98% | |
| SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kin | ||||
| 52531 | StemRegenin 1 | 1227633-49-9 | 98% |  |
| StemRegenin 1(SR1) is an antagonist of the aryl hydrocarbon receptor.SR1 is the first | ||||
| 52507 | S0859 | 1019331-10-2 | 98% |  |
| S0859, an N-cyanosulphonamide compound, reversibly inhibit NBC-mediated pH(i) recover | ||||
| 52210 | SRPIN340 | 218156-96-8 | 98% |  |
| SRPIN340 is a serine/arginine-rich protein kinase (SRPK)-specific inhibitor with an I | ||||
| 52243 | 5S rRNA modificator | 1415238-77-5 | 98% |  |
| 5S rRNA modificator is a suitable electrophile for 2-hydroxyl acylation on structured | ||||
| 52312 | SB431542 | 301836-41-9 | 98% |  |
| SB431542 is a potent and selective inhibitor ofALK5withIC50of 94 nM, 100-fold more se | ||||
| 52106 | Salirasib | 162520-00-5 | 98% |  |
| Salirasib(S-Farnesylthiosalicylic aci) is an S-farnesyl cysteine analog that interfer | ||||